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Chronic kidney disease (CKD) is a major health problem
worldwide. In Europe it is estimated that ∼16% of the general
population has CKD stages 1–4 and in US the prevalence
is similar at ∼13%. CKD is associated with increased risk of
cardiovascular disease and mortality. It is therefore impor-
tant to further our understanding regarding the molecular
determinants of CKD and find new ways to manipulate them
for therapeutic benefit. A large proportion of CKD is due to
diabetic nephropathy (DN), one of themicrovascular compli-
cations of diabetes. In the Western world, DN is the leading
cause of end-stage renal disease and kidney replacement
therapy (almost half of these patients), an immense burden
on healthcare costs. It is estimated that 40–45% of patients
with type I diabetes and 30% of patients with type II diabetes
have nephropathy.
Multiple molecular mechanisms of DN progression have
been described in recent years; however, mechanism-derived
treatments for DN are still lacking. This is partly due to
poor understanding of the detailed molecular mechanisms
underlying diabetic complications. The standard of care is to
control glycaemia but most of the time this does not stop the
occurrence of the nephropathy.
There is therefore an increasing need to better understand
molecular mechanisms of progression in DN and to develop
novel treatments that target specifically these mechanisms
and are able to slow progression of the underlying CKD in
DN.
This special issue is trying to address these goals by pub-
lishing both articles that describe novel molecular pathways
implicated in DN and novel treatment ideas.
We do hope that the papers here collected may offer the
readers an improved knowledge on innovative and original
advances in DN pathogenesis and management.
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